Skip to main navigation Skip to search Skip to main content

Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials

Research output: Contribution to journalArticlepeer-review

Abstract

We performed a study-level meta-analysis to provide more robust evidence on safety of very low LDL-cholesterol (LDL-C) levels.
Original languageEnglish
JournalEuropean Heart Journal - Cardiovascular Pharmacotherapy
DOIs
Publication statusPublished - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adverse events
  • Lipid-lowering therapies
  • Major adverse cardiovascular events
  • Very low LDL-C

Fingerprint

Dive into the research topics of 'Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials'. Together they form a unique fingerprint.

Cite this